aspect of
placebo)
→
ReceivesAction
→
evaluated in patient
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| depending on the urodynamic result | 3 | other |
| effect → be evaluated in → patient | 3 |
| negative | neutral | positive |
| 0.112 | 0.857 | 0.031 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 31.112 |